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Background-—Chronic unilateral renal artery stenosis (RAS) causes accelerated atherosclerosis in apolipoprotein E–deficient
(ApoE/) mice, but effects of restoration of renal blood flow on aortic atherosclerosis are unknown.
Methods and Results-—Male ApoE/ mice underwent sham surgery (n=16) or had partial ligation of the right renal artery (n=41)
with the ligature being removed 4 days later (D4LR; n=6), 8 days later (D8LR; n=11), or left in place for 90 days (chronic RAS;
n=24). Ligature removal at 4 or 8 days resulted in improved renal blood flow, decreased plasma angiotensin II levels, a return of
systolic blood pressure to baseline, and increased plasma levels of neutrophil gelatinase associated lipocalin. Chronic RAS resulted
in increased lipid staining in the aortic arch (33.2% [24.4, 47.5] vs 11.6% [6.1, 14.2]; P<0.05) and descending thoracic aorta (10.2%
[6.4, 25.9] vs 4.9% [2.8, 7.8]; P<0.05), compared to sham surgery. There was an increased amount of aortic arch lipid staining in
the D8LR group (22.7% [22.1, 32.7]), compared to sham-surgery, but less than observed with chronic RAS. Lipid staining in the
aortic arch was not increased in the D4LR group, and lipid staining in the descending aorta was not increased in either the D8LR or
D4LR groups. There was less macrophage expression in infrarenal aortic atheroma in the D4LR and D8LR groups compared to the
chronic RAS group.
Conclusions-—Restoration of renal blood flow at either 4 or 8 days after unilateral RAS had a beneficial effect on systolic blood
pressure, aortic lipid deposition, and atheroma inflammation. ( J Am Heart Assoc. 2016;5:e002953 doi: 10.1161/
JAHA.115.002953)
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T he Cardiovascular Outcomes in Renal AtheroscleroticLesions (CORAL) trial, the largest randomized study of
patients with renal artery stenosis (RAS) ever performed, found
that renal artery stent implantation did not provide any benefit
beyond optimal medical therapy in the occurrence of death,
cardiovascular events, or renal events in patients with moder-
ately severe atherosclerotic RAS.1 There was a modest
improvement in systolic blood pressure favoring the stent
group, but no difference in adverse clinical outcomes. The
CORAL results were similar to findings from the Angioplasty
and Stenting for Renal Artery Lesions (ASTRAL) trial2 and the
Stent Placement and Blood Pressure and Lipid-Lowering for the
Prevention of Progression of Renal Dysfunction Caused by
Atherosclerotic Ostial Stenosis of the Renal Artery (STAR) trial.3
The reasons that successful restoration of renal blood flow
did not improve cardiovascular outcomes in patients with RAS
in ASTRAL, CORAL, and STAR are not well understood. The
majority of adverse clinical events in these trials were
attributed to coronary artery disease, strongly suggesting
that a better understanding is needed of the interaction
between renal ischemia and atherogenesis. One potential
explanation for the lack of benefit in these trials is that renal
ischemia causes irreversible atherogenic changes and that
restoration of renal blood flow has no effect on mitigating the
damage to the vasculature.4 Biological plausibility of this
hypothesis is provided by numerous studies showing that
decreased renal perfusion is associated with RAS activation,5
and data from animal models showing that even short-term
elevation in angiotensin II (Ang-II) levels can accelerate the
development of atherosclerosis and lead to changes in the
arterial wall that persist even after Ang-II levels return to
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baseline.6–11 In addition, RAS has been shown to result in
elevated oxidative stress, sympathoadrenergic activation, and
impaired vasoactive responses, both within the kidney and the
systemic microcirculation.12,13
Although there are extensive data from animal models
showing that unilateral RAS leads to accelerated atheroscle-
rosis, there is surprisingly little information on what extent, if
any, these adverse vascular effects respond to revasculariza-
tion. Past studies in the rat14,15 have shown that blood
pressure normalizes and plasma renin activity decreases after
unclipping either 6 weeks or 4 months after unilateral RAS,
but effects on vascular pathology have not been studied.
Thus, the purpose of the present study was to examine
the effects of transient periods of partial unilateral renal
artery constriction on aortic atherogenesis in apolipoprotein
E–deficient (ApoE/) mice.
Methods
Surgery and Blood Pressure Measurements
Male ApoE/ mice (C57BL/6 background) purchased from
The Jackson Laboratory (Bar Harbor, ME) were fed a
standard chow diet (Certified Rodent Chow 5001; Purina
Mills, Kansas City, MO) and had free access to water.
Animals were housed and cared for according to the
guidelines proposed by the National Institutes of Health
(NIH) for the care and use of experimental animals (NIH
publication No. 85-23).
Surgery and laser Doppler imaging were performed as
previously described on 18-week-old male ApoE/ mice.16
Briefly, mice were anesthetized and a vertical incision made in
the midline of the back. The right renal artery was exposed
and a needle with an outside diameter of 0.2096 to
0.235 mm positioned on top of the artery. The vessel was
ligated by tying the sutures down firmly around the needle and
the vessel and then removing the needle. In the groups that
underwent ligature removal, mice were anesthetized on the
defined day and a vertical incision made in the midline of the
back. The right renal artery was exposed and the ligature
removed. Blood flow through the renal artery was assessed
using a 10-MHz pulsed Doppler probe before ligation,
immediately postligature placement, before ligature removal
and before being killed.
Systolic blood pressure was measured before surgery and
then at 10 and 15 days after surgery and then at 15-day
intervals in a core laboratory at the University of North
Carolina (Chapel Hill, NC) using a computerized, noninvasive,
tail-cuff system (Hatteras Instruments, Cary, NC), which has
been validated for reproducibility in acclimatized mice.17 At
each time point, the reported number is the mean of 10
measurements made at the same time each day for 5
consecutive days. Animals were habituated to the device for 1
week before blood pressures were obtained.
Tissue Analysis
Mice were euthanized 90 days after surgery, and 4% parafor-
madehyde in PBS was infused for 10 minutes at a pressure of
100 mm Hg. After tissue fixation, aortic tissue was resected
from the aortic valve to the iliac bifurcation and adventitial
tissue was carefully removed. Lipid deposition was assayed
using 0.3% Oil Red O solution as described by Weiss et al.8
Briefly, the intimal surface was exposed by a longitudinal cut
along the inner curvature of the aortic arch and descending
thoracic aorta. To quantify the extent of intimal surface
covered by Oil Red O staining, images from a digital camera
were analyzed using NIH software (ImageJ; NIH, Bethesda,
MD).
The infrarenal abdominal aorta was embedded in paraffin
blocks, sectioned, and stained with Mason’s trichrome stain
or a rat antimouse monoclonal antibody that recognizes the
murine F4/80 macrophage antigen (Serotec, Raleigh, NC).
Antibody staining was followed by secondary antibodies and
HRP-conjugated streptavidin. Staining was then visualized by
reaction with DAB (Sigma-Aldrich, St. Louis, MO).
Measurement of Plasma Levels of Ang II, NGAL
and Total Cholesterol
Plasma Ang-II concentrations were determined using a
commercially available Radioimmunoassay kit (Phoenix Phar-
maceuticals Inc., Burlingame, CA), according to the manufac-
turer’s instructions. Plasma samples prepared from blood
collected in EDTA tubes at various time points by tail bleed
were assayed in duplicates. A gamma counter was utilized to
measure counts per minute of the pellets. Results were
interpreted by natural log transformation of the data and then
compared to a standard curve.
Mouse plasma neutrophil gelatinase associated lipocalin
(NGAL) concentrations were determined utilizing by a com-
mercially available ELISA kit (R&D Systems, Minneapolis, MN),
according to the manufacturer’s instructions. Plasma samples
prepared from blood collected at various time points by mice
tail bleed in EDTA tubes were assayed in duplicates. After
addition of stop solution, optical density of samples was
immediately read in a plate reader at 450 nm along with
specified wavelength correction. Results were interpreted in
correlation with the standard curve.
Mouse plasma cholesterol levels were determined by
utilizing the commercially available Amplex Red assay kit
(catalog No.: A12216; Molecular Probes, Eugene, OR),
according to the manufacturer’s instructions, using plasma
samples prepared from blood collected at various time points
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by mice tail bleed in EDTA tubes.18 Results were interpreted
utilizing a standard curve developed using cholesterol sam-
ples provided in the kit.
Data Analysis and Statistics
Normally distributed data are presented as meanSD and
non-normally distributed data as median [25%, 75%]. Com-
parison between groups was done by Student t test, ANOVA,
1-way repeated-measures ANOVA, or Kruskal–Wallis 1-way
ANOVA (for non-normally distributed continuous variables)
followed by the Holm–Sidak method or Dunn’s multiple range
test (if groups were unequal in size). The Mantel–Haenszel chi-
square was used to analyze differences between categorical
variables. Differences were considered significant at a P value
of ≤0.05.
Results
Quantification of Reduction in Blood Flow With
Partial Constriction of Right Renal Artery
RAS was elicited in male ApoE/ mice by partial constriction
of the right renal artery resulting in an average reduction of
blood flow to the right kidney to 606% of baseline values as
measured using scanning laser Doppler perfusion imaging
(Figure 1A and 1B). Right renal blood flow was significantly
reduced compared to baseline immediately after ligature
placement and when measured 4, 8, or 90 days later
(Figure 1B). Mice that underwent sham surgery in which the
renal artery was exposed, but not ligated, had no change in
renal blood flow during the 90 days of the study (n=16).
Mice with RAS were assigned to groups in which the
ligature was removed either 4 days (D4LR group; n=6) or
8 days after surgery (D8LR group; n=11) or maintained for
90 days (chronic RAS group; n=24). At the time of killed, renal
blood flow was the same as baseline in the sham surgery and
D4LR groups, mildly impaired in the D8LR group (864%;
P<0.05) ,and severely reduced in the chronic RAS group
(4417%; P<0.05; Figure 1B). No mouse developed complete
occlusion of the right renal artery.
Chronic RAS was Associated With Loss of Renal
Mass and a Sustained Increase in Systolic Blood
Pressure
At the time of killed, 90 days after the initial surgery, there
was no difference in weight between the left and right kidneys
in the sham-operated group, the D4LR group, or the D8LR
group, whereas the right kidney was significantly smaller than
the left kidney in the chronic RAS group (Figure 1C). Body
weight was similar in all groups at the time of killed (data not
shown).
Chronic RAS elicited a mild, sustained increase in systolic
blood pressure with statistically significant blood pressure
elevation at all time points (Figure 1D; P<0.05 compared to
blood pressure before surgery). In the D8LR group, systolic
blood pressure was elevated 7 days after partial renal artery
constriction, but returned to baseline levels at 15 days and
later time points. In the D4LR group, blood pressure could not
be measured at 7 days because of the recent surgery, but
there was no elevation in systolic blood pressure at 15 days
or any later time point. Sham surgery had no effect on systolic
blood pressure during the duration of the experiment
(P=0.87).
NGAL Levels Were Increased and Ang-II Levels
Were Decreased After Restoration of Renal Blood
Flow in Mice With Partial Unilateral RAS
NGAL levels were elevated in both the D4LR and D8LR
groups, compared to the sham surgery group, when measured
at 15 days. In contrast, NGAL levels were lower in the chronic
RAS group at this time point (Figure 1E). By 30 days, NGAL
levels were similar in chronic RAS and sham surgery controls,
but remained elevated in the D4LR and D8LR groups. The
increases were similar in magnitude in both groups. At
90 days, NGAL levels in the D4LR and D8LR groups had
returned to baseline values; results similar to past studies in
humans, which showed no difference in NGAL levels mea-
sured before and 3 to 4 months after revascularization.19
Plasma Ang-II levels were increased in the chronic RAS
group at 15 days, but were similar to the sham surgery group
at 30 and 90 days (Figure 1F). Ang-II levels were decreased in
the revascularization groups after ligature removal (when
measured at 15 days) and remained suppressed for the
duration of the experiment. These results are similar to
studies in the rat two-kidney-one-clip (2K1C) model, in which
plasma renin concentrations were only 64% of baseline levels
when measured 60 days after restoration of renal blood
flow.14,15
Average total cholesterol values in mice was
277114 lg/mL. Plasma total cholesterol levels did not
change over time with chronic RAS or with restoration of renal
blood flow (Figure 2).
RAS was Associated With Increased Lipid
Deposition in the Aortic Arch and Descending
Thoracic Aorta
ApoE/ mice develop atherosclerotic lesions in the aortic
arch, primarily in the lesser curvature and at the origin of the
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Figure 1. Renal perfusion and physiological effects after unilateral renal artery ligation. Representative examples of
laser Doppler imaging of renal perfusion from the same mouse before constriction and immediately after constriction
(A) and perfusion of the right kidney at various time points in each group (B). Effects of RAS are shown by kidney
weight (meanSEM, C), systolic blood pressures measured on 5 successive days both before surgery and then 10, 15,
30, 45, 60, 75, and 90 days after surgery (D), plasma NGAL levels measured at various time points (E), and plasma
Ang-II levels measured at various time points (F). Ang-II levels were numerically higher at 30 and 90 days in the sham
surgery group compared to baseline, but these differences were not statistically significant (*P<0.05 for comparison to
sham surgery group; +P<0.05 for D8LR group compared to sham surgery group). Ang-II indicates angiotensin II; NGAL,
neutrophil gelatinase associated lipocalin; RAS, renal artery stenosis.
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great vessels. These lesions progress with age in chow-fed
mice, such as used in the present study. Interventions such as
a high-fat, high-cholesterol diet,20 infusion of Ang II,6,8 and
unilateral RAS10,11,16,21 have been shown to accelerate lipid
deposition in this area.
Lipid deposition, as determined by Oil Red O staining, was
detected in 11.6% [6.1, 14.2] of the area of the aortic arch in
the sham surgery group, similar to results from past studies in
chow-fed ApoE/ mice (Figure 3A and 3B).6,22 Chronic RAS
resulted in an approximate 3-fold increase in lipid staining in
the aortic arch compared to sham surgery (33.2% [24.4, 47.5]
vs 11.6% [6.1, 14.2]; P<0.05). In the D8LR group, there was a
2-fold increase in the aortic arch area, which stained with Oil
Red O compared to the sham surgery group (22.7% [22.1,
32.7]; P<0.05). There was no increase in lipid deposition in
the aortic arch in mice in the D4LR group (10.8% [9.1, 11.9];
P=ns [not significant]).
To determine the effect of restoration of renal blood flow
on atherogenesis within areas of low shear stress, the
descending thoracic aorta was stained with Oil Red O. There
was less lipid deposition in the descending thoracic aorta,
compared to the aortic arch, in all groups (Figure 3C). The
area of the descending thoracic aorta which stained for lipids
was similar in the sham surgery (4.9% [2.8, 7.8]), D4LR (8.9%
[4.3, 10.7]), and D8LR (5.3% [4.2, 16.0]) groups. The area of
the descending thoracic aorta, which stained for lipid
Figure 2. Total cholesterol levels after unilateral renal artery
constriction with and without revascularization. Plasma total
cholesterol levels were measured at baseline and then 15, 30, and
90 days after surgery. There were no statistically significant
differences at any point in any group as determined by ANOVA.
Figure 3. Aortic lipid deposition after unilateral renal artery
constriction with and without revascularization. Representative
examples of the aortic arch stained with Oil Red O from mice in
the sham surgery, chronic RAS, D4LR, and D8LR groups are
shown in (A). The area of the aortic arch (B) and descending
thoracic aorta (C) that stained with Oil Red O as a percentage of
total area for all mice in each of the groups (*P<0.05 vs sham
surgery). RAS indicates renal artery stenosis.
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deposition, was 2-fold higher in the chronic RAS group
compared to the sham-surgery group (10.2% [6.4, 25.9];
P<0.05).
Restoration of Renal Blood Flow Was Associated
With Less Inflammation in Aortic Atheroma
Atheroma having cholesterol clefts, calcification, acellular
necrotic core, a lipid core, and/or a fibrous cap were
identified in the infrarenal aorta in 2 of 6 (33%), 4 of 11 (36%),
and 13 of 24 (54%) mice in the D4LR, D8LR, and chronic RAS
groups, respectively (Figure 4). In contrast, no atheroma were
observed in the 16 mice in the sham surgery group.
Comparing the 3 groups with renal artery ligation versus
sham surgery showed that any renal ischemia was associated
with a statistically significant increase in the presence of
infrarenal aortic atheroma (19 of 41 [46%] vs 0 of 16;
P=0.008).
There was significant macrophage expression within
atheroma from mice with chronic RAS (Figure 5A), consistent
with previous studies showing that chronic RAS is associated
with a vascular inflammatory reaction.10,11,16 Macrophages
were detectable within atheroma from mice in the D4LR and
D8LR groups, but at levels significantly less than observed in
atheroma from mice in the chronic RAS group (Figure 5B).
Discussion
These results demonstrate that restoration of renal blood flow
after either 4 or 8 days of renal ischemia was associated with
decreased aortic atherosclerotic changes compared to
chronic RAS. Importantly, however, RAS for 8 days was
associated with accelerated atherogenesis in the aorta of
ApoE/ mice, compared to the sham surgery group, as
determined by the presence of atheroma in the infrarenal
aorta and lipid deposition in the aortic arch. The increased
atherogenesis in the aorta was observed despite normaliza-
tion of renal blood flow, a decrease in plasma Ang-II levels to
subnormal levels, and a return of systolic blood pressure to
baseline after ligature removal. These results demonstrate
that even relatively brief periods of renal ischemia cause
accelerated atherosclerosis, and strongly suggest that the
benefits of restoration of renal blood flow in ApoE/ mice
with unilateral RAS are dependent on the length of time of
renal ischemia.
Figure 4. Atheroma in the infrarenal abdominal aorta. Representative sections from the
distal one third of the descending aorta from various groups stained with Trichrome
showing the formation of atheroma (original magnification, 1009). RAS indicates renal
artery stenosis.
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Figure 5. Atheroma inflammation after unilateral renal artery constriction with and without revascularization. Representative
sections from atheroma in the distal one third of the descending aorta from various groups stained with a rat antimouse
monoclonal antibody that recognizes the murine F4/80 macrophage antigen (A). The area of the atheroma that had visible
staining for macrophages is quantified in (B). There were no atheroma in the mice that underwent sham surgery (*P<0.05 vs
sham surgery group). RAS indicates renal artery stenosis.
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A novel finding of this study is that early restoration of
renal perfusion reduced the inflammatory response observed
in aortic atheroma in mice with chronic RAS. Abdominal aortic
atheroma were present in mice in the D4LR, D8LR, and
chronic RAS groups, whereas there were no atheroma in the
16 mice that underwent sham surgery. There was significant
accumulation of macrophages within atheroma in the chronic
RAS group, consistent with past studies that showed
pronounced inflammatory response in the aorta 4 weeks10,11
and 90 days16 after unilateral renal artery clipping in ApoE/
mice. Restoration of renal blood flow either 4 or 8 days after
unilateral partial RAS was associated with lower levels of
macrophage infiltration than chronic RAS, strongly suggesting
that restoration of renal blood flow has an anti-inflammatory
effect. A past study in pigs with unilateral RAS found that
renal revascularization reduced, but did not normalize, either
systemic or renal markers of inflammation.23
In addition to an anti-inflammatory effect, there are several
other mechanisms that may partially explain how restoration
of renal blood flow reduces aortic atherosclerosis. Abrupt
onset of renal ischemia in the 2K1C model is associated with
RAS activation, and Ang-II has profound effects on the
vasculature, including modulating vascular tone, stimulating
smooth muscle cell responses, regulating production of
growth factors and extracellular matrix, and enhancing
macrophage infiltration into the vascular wall.6–11 Exposure
to elevated levels of exogenous Ang-II6,8,24 and endogenous
Ang-II10,11 have been shown to stimulate formation of
atherosclerotic lesions in ApoE/ mice. The elevation of
Ang-II levels observed 15 days after surgery in mice with
chronic RAS in the current study was in contrast to the
persistent reduction in Ang-II levels observed in mice that had
restoration of renal blood flow. Other mechanisms that have
been shown to contribute to atheroma formation in various
models of RAS and which may be modulated by a reduction in
the time of renal ischemia include regulation of nitric oxide
levels, generation of reactive oxygen species, low-density
lipoprotein oxidation, and upregulation of early growth
response-1, an immediate early gene product and zinc finger
transcription factor that has been implicated in atherogene-
sis.13,25,26
Another novel finding of this study is the time course of
NGAL levels in the 2K1C model of ApoE/ mice with and
without revascularization. Plasma levels of NGAL were
decreased after 15 days of renal ischemia in the chronic
RAS model and then returned to baseline at 30 and 90 days.
This study is the first to show a decrease in NGAL levels in a
mouse model of renal injury. Past studies demonstrating
that NGAL is rapidly and consistently upregulated in the
ischemic mouse kidney27–29 examined early time points
(usually within a few hours of injury) and/or ischemia-
reperfusion injury. In contrast, the present study examined
NGAL levels at delayed time points in the presence of
persistent renal injury.
In contrast to the decrease in NGAL levels observed at
15 days in the chronic RAS group, NGAL levels were
increased at 15 and 30 days in mice that had restoration of
renal blood flow. Because plasma NGAL is a powerful and
independent predictor of acute kidney injury and renal
repair,30,31 the increased levels of NGAL observed after
revascularization would suggest that restoration of renal
blood flow leads to a prolonged renal repair process.27,28
Additional studies are needed to define whether the changes
in plasma NGAL levels were renal in origin given that NGAL
exists in blood in 3 different molecular forms—as a monomer,
homodimer, and heterodimer32—with activated neutrophils
predominantly releasing homodimeric NGAL, whereas injured
distal tubule renal epithelial cells largely secrete monomeric
NGAL.33,34
This study provides further evidence that restoration of
renal blood flow in rodents with unilateral RAS results in a
rapid and persistent decrease in plasma markers of RAS
activation. In both of the revascularization groups, Ang-II
levels were decreased when measured after restoration of
renal blood flow (at 15 days) and remained suppressed for the
duration of the experiment (in contrast, plasma Ang-II levels
were increased at 15 days in the chronic RAS group).
Although numerous studies have documented activation of
the RAS with abrupt onset of unilateral renal ischemia, much
less is known about the time course of RAS activation after
revascularization. Results of the current study are similar to
those noted in past studies of the 2K1C model in female,
white Wistar rats. In that model, unilateral renal artery clipping
was associated with a marked increase in plasma renin
concentration when measured 30.91.3 days later (638% of
baseline). Removal of the clip resulted in a marked decrease
in plasma renin concentration to 82% of baseline at 7 days
and 64% of baseline at 60 days.14,15 Plasma renin levels in
2K1C hypertensive rats declined to levels below those of
sham controls in as little as 3 hours after unclipping.35
The results of this study should be interpreted with several
important caveats. One is that the mice in the transient RAS
groups underwent a second surgery for ligature removal. The
comparison groups had a single surgery, and thus we cannot
exclude the possibility that the second surgery contributed to
vascular pathology. Second, we did not establish the time
course over which renal artery flow returned to baseline
levels. Doing this with laser Doppler perfusion imaging would
have required additional surgeries, which would have con-
founded the results. Third, we were unable to quantify blood
pressure early after renal artery constriction because BP
measurements were unreliable in the perioperative period.
Clinical studies examining the effects of percutaneous
revascularization in patients with severe RAS have failed to
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show any benefit on all-cause mortality or cardiovascular
outcomes.1–3 This lack of benefit is despite successful
restoration of blood flow in >95% of cases. The current study
suggests that the duration of renal ischemia is an important
variable in determining effects on atherogenesis and that
timely, and not just successful, reestablishment of normal
renal blood flow is necessary to have beneficial effects on
RAS-induced development of atherosclerosis.
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